Core Viewpoint - Scienture Holdings, Inc. has announced a registered direct offering to institutional investors, aiming to raise approximately $3.9 million by selling 3,225,000 shares of common stock at $1.20 per share, with the offering expected to close on August 15, 2025 [1]. Group 1: Offering Details - The offering involves 3,225,000 shares at an offering price of $1.20 per share, with gross proceeds expected to be around $3.9 million before fees and expenses [1]. - Maxim Group LLC is acting as the sole placement agent for this offering [2]. - The offering is made under an effective shelf registration statement on Form S-3, filed with the SEC on August 1, 2025, and declared effective on August 8, 2025 [3]. Group 2: Company Overview - Scienture Holdings, Inc. operates through its subsidiary, Scienture, LLC, focusing on developing and distributing novel specialty pharmaceutical products to meet unmet market needs [5]. - The company is committed to enhancing value for patients, physicians, and caregivers through its unique specialty products [5]. - Scienture's assets in development span various therapeutic areas and market segments [5].
Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock